Product Highlight-Vaxneuvance

1. Elicits a higher immune response for serotype 3

2. Adds key disease-causing serotypes 22F and 33F

3. Shows non-inferior immune responses compared to PCV13 (13 shared serotypes)

Reference:
1. Vaxneuvance™ Product Insert Malaysia. Available at: Product Search, National Pharmaceutical Regulatory Agency https://quest3plus.bpfk.gov.my/pmo2/index.php

Further information is available in MIMS section 12b.

For healthcare professionals only.